Professor, Medicine, National Jewish Health
Pulmonology
Dr. Charles L. Daley, MD
|
|
Give Review
Charles Daley works in the field of Pulmonology. He researched medicine at University of Mississippi School of Medicine. He over the years received 1 awards: "Regional Top Doctor". Dr. Charles L. Daley is a published MD. He published 62 publications, including: 'Mycobacterial Lung Disease Complicating HIV Infection.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Blood transcriptional biomarkers for active TB among US patients: A case-control study with systematic cross-classifier evaluation.
- Improvement in Quality of Life Following Therapy for Mycobacterium abscessus Group Lung Infection: A Prospective Cohort Study.
- Nontuberculous mycobacteria.
- Transcriptional adaptation of drug-tolerant Mycobacterium tuberculosis during treatment of human tuberculosis.
- The tolerability of linezolid in the treatment of nontuberculous mycobacterial Disease.
- Genome Sequencing of Mycobacterium abscessus Isolates from Patients in the United States and Comparisons to Globally Diverse Clinical Strains.
- Interferon-Gamma Release Assays.
- Nontuberculous Mycobacterial infections at San Francisco General Hospital.
- Treatment of Pulmonary nontuberculous mycobacterial infections: many questions remain.
- The geographic diversity of nontuberculous mycobacteria isolated from Pulmonary samples: an NTM-NET collaborative study.
- Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States.
- Clinical Significance of a First Positive Nontuberculous Mycobacterial Culture in Cystic Fibrosis.
- A Summary of the Third Global Interferon-γ Release Assay Symposium.
- A Summary of Meeting Proceedings on Addressing Variability around the Cut Point in Serial Interferon-γ Release Assay Testing.
- Mycobacterial infections.
- Management of multidrug resistant tuberculosis.
- In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease.
- Mycobacterium avium complex and Lung cancer: chicken or egg? Both?
- Pulmonary resection and lung transplantation for Bronchiectasis.
- Translating basic science insight into public health action for multidrug- and extensively drug resistant-tuberculosis.
- Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex Disease.
- Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?
- XDR tuberculosis.
- Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus Pulmonary disease.
- Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
- Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens.
- Effects of gender and age at diagnosis on Disease progression in long-term survivors of cystic fibrosis.
- Update in tuberculosis 2009.
- Nontuberculous mycobacterial Disease in transplant recipients: early diagnosis and treatment.
- Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and Chronic viral hepatitis.
- Diagnosis and treatment of Infections due to Mycobacterium avium complex.
- A novel assay for screening patients for latent tuberculosis Infection prior to anti-TNF therapy.
- Detailed analysis of the radiographic presentation of Mycobacterium kansasii Lung disease in patients with HIV infection.
- IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis.
- Quantitative impact of human immunodeficiency virus Infection on tuberculosis dynamics.
- Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
- Nontuberuclous mycobacterial Disease: updated diagnostic criteria for an under-recognized infectious complication of anti-tumor necrosis factor therapy.
- Treatment outcomes of patients with HIV and tuberculosis.
- Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from Disease.
- Moxifloxacin versus ethambutol in the first 2 months of treatment for Pulmonary tuberculosis.
- Factors related to response to intermittent treatment of Mycobacterium avium complex Lung disease.
- Tuberculosis in healthcare workers: a molecular epidemiologic study in San Francisco.
- Prevention of tuberculosis in HIV-infected patients.
- Mycobacterium tuberculosis Infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing.
- Molecular epidemiology: a tool for understanding control of tuberculosis transmission.
- Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach.
- Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water.
- Mortality prediction in Pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
- Potential public health impact of new tuberculosis vaccines.
- Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.
- A systematic review of the clinical significance of Pulmonary Mycobacterium kansasii isolates in HIV infection.
- Tuberculosis transmission based on molecular epidemiologic research.
- Tuberculosis contact investigations: please don't fail me now.
- A molecular epidemiological assessment of extraPulmonary tuberculosis in San Francisco.
- Effect of drug resistance on the generation of secondary cases of tuberculosis.
- Rifampin and pyrazinamide for treatment of latent tuberculosis Infection: is it safe?
- Yield of sputum induction in the diagnosis of Pleural tuberculosis.
- Pulmonary disease caused by rapidly growing mycobacteria.
- Epidemiology of human Pulmonary infection with nontuberculous mycobacteria.
- Transmission of multidrug-resistant tuberculosis: limited by man or nature?
- Mycobacterial Lung Disease Complicating HIV Infection.
Schools
Univ Of Ms Sch Of Med
University Calif San Francisco
Procedures Preformed
- Bronchoscopy
- Thoracentesis
Conditions Treated
- Asthma
- Atelectasis
- Bronchiectasis
- Bronchitis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
UCSF -
University of Mississippi School of Medicine
Hospital
-
National Jewish Health -
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1316027915 | |
| NPPES Provider LastName | DALEY | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 802062761 | |
| NPPES Provider State | CO | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 54.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316027915 |
| Last Name Of The Provider | DALEY |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Eva B. Gottschall, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cristian T. Arvinte, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel L. Zemans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey Zamarripa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael L. Darnell, MD |
|
|
Dr. Michael D. Iseman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew D. Suskin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Creticus P. Marak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John P. Wilkins, MD |
|
|
Dr. Valdemar Lindquist, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Scoggins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James K. O'Brien, MD |